A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: Comparisons of sympathetic activity and left atrial size

Journal of Interventional Cardiac Electrophysiology

Volumn 38, Issue 2, 2013, Pages 79-84

  Akutsu, Yasushi ^a,d   Kaneko, Kyouichi ^a   Kodama, Yusuke ^a,b   Miyoshi, Fumito ^a,c   Li, Hui Ling ^a,d   Watanabe, Norikazu ^a   Asano, Taku ^a   Tanno, Kaoru ^a   Suyama, Jumpei ^a   Namiki, Atsuo ^b   Gokan, Takehiko ^a   Kobayashi, Youichi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANTO ROSAI HOSPITAL   (Japan)

^c Takatsu General Hospital   (Japan)

^d Showa University Karasuyama Hospital   (Japan)

Author keywords

Brain natriuretic peptide; Electrical remodeling; P wave duration; Paroxysmal atrial fibrillation; Persistent atrial fibrillation; Sympathetic nervous system innervation

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; SODIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; DIGITAL CALIPER; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPATHETIC TONE;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE VOLUME;

EID: 84888031158     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-013-9818-2     Document Type: Article

References (23)

1. Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace, 14, 528-606.
2. Nattel, S., Burstein, B., & Dobrev, D. (2008). Atrial remodeling and atrial fibrillation: mechanisms and implications. Circulation: Arrhythmia and Electrophysiology, 1, 62-73.
3. de Vos, C. B., Pisters, R., Nieuwlaat, R., Prins, M. H., Tieleman, R. G., Coelen, R. J., et al. (2010). Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. Journal of the American College of Cardiology, 55, 725-31.
4. Anné, W., Willems, R., Holemans, P., Beckers, F., Roskams, T., Lenaerts, I., et al. (2007). Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model. Journal of Molecular and Cellular Cardiology, 43, 148-158.
5. Iwasaki, Y. K., Nishida, K., Kato, T., & Nattel, S. (2011). Atrial fibrillation pathophysiology: implications for management. Circulation, 124, 2264-74.
6. Todd, D. M., Fynn, S. P., Walden, A. P., Hobbs, W. J., Arya, S., & Garratt, C. J. (2004). Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation, 109, 1434-39.
7. Benjamin, E. J., Chen, P. S., Bild, D. E., Mascette, A. M., Albert, C. M., Alonso, A., et al. (2009). Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation, 119, 606-18.
8. Akutsu, Y., Kaneko, K., Kodama, Y., Li, H. L., Suyama, J., Shinozuka, A., et al. (2011). Iodine-123 mIBG imaging for predicting the development of atrial fibrillation. JACC: Cardiovascular Imaging, 4, 78-86.
9. Shibazaki, K., Kimura, K., Fujii, S., Sakai, K., & Iguchi, Y. (2012). Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke. The American Journal of Cardiology, 109, 1303-7.
10. Wazni, O. M., Martin, D. O., Marrouche, N. F., Latif, A. A., Ziada, K., Shaaraoui, M., et al. (2004). Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation, 110, 124-7.
11. Kallergis, E. M., Manios, E. G., Kanoupakis, E. M., Mavrakis, H. E., Goudis, C. A., Maliaraki, N. E., et al. (2010). Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic peptide prohormone levels in patients with persistent atrial fibrillation. The American Journal of Cardiology, 105, 90-4.
12. Perez, M. V., Dewey, F. E., Marcus, R., Ashley, E. A., Al-Ahmad, A. A., Wang, P. J., et al. (2009). Electrocardiographic predictors of atrial fibrillation. American Heart Journal, 158, 622-8.
13. Magnani, J. W., Johnson, V. M., Sullivan, L. M., Gorodeski, E. Z., Schnabel, R. B., Lubitz, S. A., et al. (2011). P wave duration and risk of longitudinal atrial fibrillation in persons ≥60 years old (from the Framingham Heart Study). The American Journal of Cardiology, 107, 917-21.
14. Vassilikos, V., Dakos, G., Chatzizisis, Y. S., Chouvarda, I., Karvounis, C., Maynard, C., et al. (2011). Novel non-invasive P wave analysis for the prediction of paroxysmal atrial fibrillation recurrences in patients without structural heart disease: a prospective pilot study. International Journal of Cardiology, 153, 165-72.
15. Aytemir, K., Amasyali, B., Kose, S., Kilic, A., Abali, G., Oto, A., et al. (2004). Maximum P-wave duration and P-wave dispersion predict recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation. Journal of Interventional Cardiac Electrophysiology, 11, 21-7.
16. Casaclang-Verzosa, G., Gersh, B. J., & Tsang, T. S. (2008). Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology, 51, 1-11.
17. Goetze, J. P., Friis-Hansen, L., Rehfeld, J. F., Nilsson, B., & Svendsen, J. H. (2006). Atrial secretion of B-type natriuretic peptide. European Heart Journal, 27, 1648-50.
18. Tveit, A., Seljeflot, I., Grundvold, I., Abdelnoor, M., Arnesen, H., & Smith, P. (2009). Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. International Journal of Cardiology, 131, 234-9.
19. Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., et al. (2004). Plasma natriuretic peptide levels and the risk of cardiovascular events and death. The New England Journal of Medicine, 350, 655-63.
20. Tsang, T. S., Gersh, B. J., Appleton, C. P., Tajik, A. J., Barnes, M. E., Bailey, K. R., et al. (2002). Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology, 40, 1636-44.
21. Jaïs, P., Peng, J. T., Shah, D. C., Garrigue, S., Hocini, M., Yamane, T., et al. (2000). Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. Journal of Cardiovascular Electrophysiology, 11, 623-5.
22. Jahangir, A., & Murarka, S. (2010). Progression of paroxysmal to persistent atrial fibrillation factors promoting the HATCH score. Journal of the American College of Cardiology, 55, 732-4.
23. Dilaveris, P., Batchvarov, V., Gialafos, J., & Malik, M. (1999). Comparison of different methods for manual P wave duration measurement in 12-lead electrocardiograms. Pacing and Clinical Electrophysiology, 22, 1532-8.